Country Profile

Iran

Iran is a significant market for Indian pharmaceutical exports — $73.6M in FY 2025–26. Vaccines accounts for 76% of shipments, with vaccines contributing $55.7M.

🇮🇷 $73.6M · 0.5× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$73.6M
Exports FY2025–26 DGCIS
0.5×
Growth FY2015→2026
76%
Vaccines Share
5
Product Categories Supplied
12
Years of Trade Data
Iran is a significant market for Indian pharmaceutical exports — $73.6M in FY 2025–26. Vaccines accounts for 76% of shipments, with vaccines contributing $55.7M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $55.7M (75.7%) Medicine Ingredients $9.99M (13.6%) Medicines $6.64M (9.0%) Surgical & Hospital Supplies $718K (1.0%) Traditional & Herbal $525K (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Iran in the RBI overseas direct investment dataset (2011–2026).